Personal Care Formulations
US-2024245591-A1 · Jul 25, 2024 · US
US10987292B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10987292-B2 |
| Application number | US-201315035648-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 11, 2013 |
| Priority date | Nov 11, 2013 |
| Publication date | Apr 27, 2021 |
| Grant date | Apr 27, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein is a cost-effective and potent preservative system for a composition comprising a salicylate salt and a benzoate salt in an amount of from 0.2 weight % to 0.5 weight % by total weight of the composition and in a molar ratio of salicylate to benzoate of 1:6 to 1:1.2, wherein the composition has a pH of 5 or less. Further provided herein is a method of using a combination of a salicylate salt and a benzoate salt in a preservative system in a composition, and a method of preserving a composition.
Opening claim text (preview).
We claim: 1. A composition comprising a preservative system, wherein the preservative system comprises a salicylate salt and a benzoate salt, wherein a total amount of the salicylate salt and the benzoate salt is from 0.2 to 0.6 weight % by total weight of the composition, wherein a weight ratio of the salicylate to the benzoate is 1:5 to 1:1, and wherein the pH of the composition is from 4 to 4.5. 2. The composition of claim 1 , wherein the molar ratio of the salicylate salt to the benzoate salt is 1:4.5 to 1:1.2. 3. The composition of claim 1 , wherein the molar ratio of the salicylate salt to the benzoate salt is 1:3.4 to 1:1.2. 4. The composition of claim 1 , wherein the molar ratio of the salicylate salt to the benzoate salt is 1:3.33. 5. The composition of claim 1 , wherein the salicylate salt comprises sodium salicylate. 6. The composition of claim 1 , wherein the benzoate salt comprises sodium benzoate. 7. The composition of claim 1 , wherein the preservative system consists of the salicylate salt and the benzoate salt. 8. The composition of claim 1 , wherein the composition is free of preservatives other than those of the preservative system. 9. The composition of claim 1 , wherein the total amount of the salicylate salt and the benzoate salt is 0.25 to 0.4 weight %, by total weight of the composition. 10. The composition of claim 1 , wherein the total amount of the salicylate salt and the benzoate salt is 0.2 weight %, 0.25 weight %, 0.3 weight %, 0.35 weight %, 0.4 weight %, by total weight of the composition. 11. The composition of claim 1 , wherein the total amount of the salicylate salt and the benzoate salt is 0.4 weight % by total weight of the composition. 12. The composition of claim 1 , wherein the salicylate salt is sodium salicylate and the benzoate salt is sodium benzoate. 13. The composition of claim 12 , wherein the weight ratio of sodium salicylate to sodium benzoate is 1:4.7 to 1:3. 14. The composition of claim 12 , wherein the weight ratio of sodium salicylate to sodium benzoate is one of 1:5, 1:4.7, 1:4.5, 1:4, 1:3, 1:3.5, 1:2.5, 1:2, or 1:1.5. 15. The composition of claim 1 , wherein the composition is a liquid cleaning composition. 16. The composition of claim 12 , wherein the weight ratio of sodium salicylate to sodium benzoate is 1:3, and adequate microrobustness is achieved with an AUC value of greater than 75, as compared to an inadequate microrobustness with an AUC value of lower than 75 when salicylate is absent. 17. The composition of claim 1 , wherein the salicylate:benzoate weight ratio is 1:3, the total concentration of salicylate and benzoate is 0.4 weight %, and adequate microrobustness is achieved with an AUC value of greater than 75, as compared to an inadequate microrobustness with an AUC value of lower than 75 when salicylate is absent. 18. The composition of claim 1 , wherein the salicylate:benzoate weight ratio is 1:5, adequate microrobustness is achieved at pH values of 4 to 4.5 with an AUC value of greater than 75, as compared to an inadequate microrobustness with an AUC value of lower than 75 when the weight ratio of salicylate:benzoate is reduced further. 19. The composition of claim 1 , which is selected from body lotions, ointments, creams and salves.
Washing or bathing preparations · CPC title
Anti-perspirants or body deodorants (deodorisation of air A61L9/00) · CPC title
Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses · CPC title
with carboxyl groups directly bound to carbon atoms of aromatic rings · CPC title
At least two compounds being classified in the same subclass of A61K8/18 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.